About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Gene That Predicts Post-surgical Survival from Brain Metastasis of Breast Cancer Patients Identified

by Rajashri on September 3, 2009 at 8:16 PM
Font : A-A+

 Gene That Predicts Post-surgical Survival from Brain Metastasis of Breast Cancer Patients Identified

A gene that may play a role in breast cancer metastasis to the brain has been identified by researchers at the National Cancer Institute, according to a report in Molecular Cancer Research, a journal of the American Association for Cancer Research.

Diane Palmieri, Ph.D., a staff scientist at the NCI, said Hexokinase 2 overexpression was more highly expressed in brain metastasis in patients with breast cancer than in primary breast tumors.

Advertisement

"Importantly, this study was conducted in human tissue rather than animal models, so we are able to extrapolate data without the problems inherent in animal studies," said Palmieri.

Brunhilde Felding-Habermann, Ph.D., an associate professor at The Scripps Research Institute, said the findings are a major step forward in potential breast cancer treatments.
Advertisement

"Improvements in breast cancer therapy have made prognoses like brain metastasis a growing problem, and this research points to a potential target for future therapies," said Felding-Habermann.

Researchers performed analyses on both primary tumors and brain metastases. They found higher levels of Hexokinase 2 in brain metastases compared with unlinked primary tumors. Among resected brain metastases, these higher levels of Hexokinase 2 were linked with worse survival. The median survival for patients with high levels of Hexokinase 2 expression in their brain metastasis was 9.6 months compared with 17.5 months for those with lower expression.

Palmieri said that Hexokinase 2 plays a key role in glucose metabolism, which provides the energy tumors need to grow. It also impacts the cell survival process, apoptosis.

"Potential therapies would need to turn off this gene and thus starve the tumor of its growth potential," said Palmieri.



Source: Eurekalert
RAS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
Test Your Knowledge on Lung Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer DNA Finger Printing Breast Biopsy Parkinsons Disease Pagets disease of the breast Mastitis Cancer and Homeopathy Parkinsons Disease Surgical Treatment Breast Cancer Facts Cancer Facts 

Most Popular on Medindia

Noscaphene (Noscapine) Sanatogen Hearing Loss Calculator Find a Doctor Color Blindness Calculator Selfie Addiction Calculator Iron Intake Calculator Accident and Trauma Care Daily Calorie Requirements Sinopril (2mg) (Lacidipine)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use